GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [CGM] my dawn phenomenon barely changed and that surprised me — 11 comments in the full submission. View in context.
71
c/t2dglp1·submitted 9 days ago by u/amylin_amy

[CGM] my dawn phenomenon barely changed and that surprised me

CGMbranch of 7 comments

hypoglycaemia. That is the whole post, but I will justify it. Everything else people worry about in c/meta is downstream of it. Titration speed, early fullness, the endless dose arguments — most of it resolves if you sort hypoglycaemia out first, and almost nobody does. I say this having got it wrong for 5 months. My…

Read the full submission and all 11 comments →

This branch

7 comments, started 8 days ago
u/neha_rahimi9 points·8 days ago

Yeah, glycaemic control is the original use.

replysharereportpermalink
[removed]7 points·7 days ago

[removed by moderator]

replysharereportpermalink
u/hamza_weiss6 points·7 days ago

How many weeks between the two measurements?

replysharereportpermalink
u/meal_prep_mira5 points·7 days ago

the hs-CRP change is the signal

replysharereportpermalink
u/hamza_weiss2 points·7 days ago

CGM traces tell a story, numbers alone do not

replysharereportpermalink
u/fridge_door_no1 point·7 days ago·edited

glycaemic control first, that is the original indication

replysharereportpermalink
u/amylin_amyOPamylin1 point·7 days ago

Maintenance for 20 months now. Weight moves within about 3kg and the dose is a quarter of what it peaked at.

replysharereportpermalink

← back to the whole thread

About c/t2dglp1

Type 2 diabetes as the original indication: A1c trajectories, CGM traces, hypoglycaemia risk when stacked with sulfonylureas or insulin, metformin combinations, and why the weight-loss conversation sometimes drowns out the glycaemic one.

36kmembers
62submissions
Jun 2024created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/t2dglp1 rules
  1. Insulin and sulfonylurea interactions are a real hypo risk. Do not hand-wave them.
  2. Post A1c with units and the assay date.
  3. No medication-stopping advice. Ever.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.